首页> 美国卫生研究院文献>Asian Pacific Journal of Cancer Prevention : APJCP >The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-Line Chemotherapy

【2h】

The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-Line Chemotherapy

机译：三联线一线化疗治疗转移性结直肠癌患者的侧支意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Recent data have shown that right-sided colon cancer carries poorer prognosis compared to left-sided tumors. This study was aimed to evaluate the progression-free survival, overall survival of patients with metastatic colon cancer of right-sided versus left-sided primaries treated with triplet chemotherapy regimen.

机译：最近的数据表明，与左侧肿瘤相比，右侧结肠癌的预后较差。这项研究的目的是评估接受三重化疗方案治疗的右侧和左侧原发性转移性结肠癌患者的无进展生存期和总体生存期。

著录项

期刊名称 Asian Pacific Journal of Cancer Prevention : APJCP
作者
Shouki Bazarbashi; Ayman T Omar; Leen Raddaoui; Ahmed Badran; Ahmed Alzahrani; Ali Aljubran; Tusneem Elhassan;
展开▼
作者单位

展开▼
年(卷),期 2019(20),10
年度 2019
页码 -1
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
Colorectal cancer; sidedness; chemotherapy;

机译：大肠癌;侧面;化学疗法;

相似文献

外文文献
中文文献
专利

1. Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer [J] . Mahmoud A. Elshenawy, Ahmed Badran, Ali Aljubran, World Journal of Surgical Oncology . 2020 ,第1期

机译：初始不可切播的转移性结肠直肠癌患者一线三联化疗和Bevacizumab后手术切除的存活效果
2. Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer [J] . S. Bazarbashi, A. M. Hakoun, A. M. Gad, Current oncology . 2019 ,第1期

机译：一线三联体后二线化疗对转移性结直肠癌患者的疗效
3. Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers [J] . Gemma Bruera, Silvia Massacese, Francesco Pepe, Therapeutic advances in medical oncology. . 2019 ,第12期

机译：RAS野生型转移性结直肠癌患者的三联化疗加入西妥昔单抗的密集第一线FIR-C / FOX-C协会：药物孕母标综合症的初步期II数据和预测个体限制毒性综合征
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer [O] . Mahmoud A. Elshenawy, Ahmed Badran, Ali Aljubran, 2020

机译：初始不可切播的转移性结肠直肠癌患者一线三联化疗和Bevacizumab后手术切除的存活效果
7. Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer [O] . Mahmoud A. Elshenawy, Ahmed Badran, Ali Aljubran, 2020

机译：初始不可切播的转移性结肠直肠癌患者一线三联化疗和Bevacizumab后手术切除的存活效果

The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-Line Chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅